Chloroquine has been extensively used in mass drug administrations, which may have contributed to the emergence and spread of resistance. It is recommended to check if chloroquine is still effective in the region prior to using it. Hydroxychloroquine false positive drug test Plaquenil bone pain Hydroxychloroquine Plaquenil Chloroquine Aralen Quinacrine Atabrine What are anti-malarial drugs, and why are they used to treat lupus? Hydroxychloroquine Plaquenil, chloroquine Aralen, and quinacrine Atabrine are medications that were originally used to prevent or treat malaria. Today’s AMs are hydroxychloroquine Plaquenil®, chloroquine Aralen®, and quinacrine Atabrine®. Quinacrine is no longer marketed in the U. S.; it can be dispensed by a compounding pharmacy, although insurance companies may not pay for it. The antimalarial quinine was first used to treat cutaneous lupus in 1834. Chloroquine is a medication used to prevent and to treat malaria in areas where malaria is known to be sensitive to its effects. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. It is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. The Centers for Disease Control and Prevention recommend against treatment of malaria with chloroquine alone due to more effective combinations. In areas where resistance is present, other antimalarials, such as mefloquine or atovaquone, may be used instead. Chloroquine cutaneous lupus Chloroquine shortage coronavirus treatment, lupus., Drug spotlight on hydroxychloroquine Lupus Foundation of America Hydroxychloroquine sulfate hair lossPlaquenil eye painPlaquenil and antacidsPlaquenil cause fatigue Note that adverse cutaneous reactions to hydroxychloroquine are reported to affect more than 30% of patients with dermatomyositis, compared to a lower risk of rash in patients with cutaneous lupus erythematosus. If a rash appears, hydroxychloroquine should be withdrawn and may be restarted at a lower dose. Less common skin side effects may include Hydroxychloroquine DermNet NZ. Chloroquine - Wikipedia. Cutaneous Lupus Erythematosus American Skin Association. Jul 30, 2019 Most of the patients described were African or of African descent with dark skin who had been exposed to the sun. One was a Hispanic patient who developed vitiligo-like skin depigmentation after 1 month of chloroquine therapy for cutaneous lupus erythematosus. The skin rapidly repigmented after discontinuation of chloroquine therapy. A trial conducted in 1953 investigated the effects of Chloroquine Aralen treatment on 30 people with discoid lupus. Researchers concluded that treatment with Chloroquine furnished significant improvement in early cases of dermatological lupus symptoms. Side effects Most people do not experience side effects from taking Aralen. The antimalarial quinine was first used to treat cutaneous lupus in 1834. Subsequent reports in 19 showed good results with another quinine-like drug in the treatment of both discoid and subacute cutaneous lupus. In 1941, discoid lupus patients were treated successfully with Atabrine, a compound developed in Germany in the 1920s.